BMS’ Boerner Bets On AI-Driven R&D In India, Points To Potential For MS, Lupus Drugs

Bristol Myers Squibb CEO Christopher Boerner is looking to India to house the the company’s largest R&D site outside of the US, channeling the country's IT expertise to expand its AI-driven small-molecule research. He also wants to bring its drugs to treat multiple sclerosis and Lupus to India.